HOB has always attached great importance to technology innovation. “Innovation” is one of our core competitiveness that differentiates us from others. Every year, we ensure that a higher proportion of the operating income is invested in R&D. We have established a global world-class R&D center with operation spaces of nearly 1,000 square meters in Suzhou, China, and 300 square meters in California, US. The R&D center is led by scientists with decades of IVD R&D experience, and operated through a well experienced product development team.

We have established a comprehensive and technology-diversified R&D pipeline of products such as chemiluminescent paramagnetic microparticle assays (BioCLIA), as well as enzyme-linked immunosorbent assays (BioLISA) and line immuno assays (BioLINE). We have obtained 39 patents and the R&D center has been recognized as the Immunodiagnostic Engineering Technology Research Center of Jiangsu Province, and has participated in the industry-university research projects including National High-tech R&D Program (the 863 Program).